In advance of November 10, 2026 GDUFA goal date, three commercial lots of Preservative-Free Ketamine have been successfully manufactured in ...
Dublin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Manufacturing Process Validation (Nov 17th - Nov 18th, 2025)" training has been added to ResearchAndMarkets.com's offering. This ...
Dublin, April 29, 2026 (GLOBE NEWSWIRE)-- The "Process Validation Guidance & Requirements Training Course (June 24th - June 25th, 2026)" training has been added to ResearchAndMarkets.com's offering.
Inadequate validation of manufacturing processes, failure to conduct microbiological testing of drugs and keeping a facility in a poor state of repair, prompted the US Food and Drug Administration ...
Countless Warning Letters or FDA 483s include the following violations: “Failure to ensure, where the results of a process cannot be fully verified by subsequent inspection and test, that the process ...
TCI Co., Ltd. - BioCosme PABP BRANCH was advised of significant violations identified during a U.S. Food and Drug Administration (FDA) inspection of your facility. Promptly address the violations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results